Indications and uses
for the treatment of acne dries up acne pimples helps prevent new acne pimples
CLENZIDERM PORE THERAPY
- Manufacturer
- OMP, INC. | PURETEK CORPORATION | Ei INC.
- Effective date
- 2011-12-15
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:30:24
Label at a glance#
ProductCLENZIDERM PORE THERAPY ACNE TREATMENT
Active ingredientSALICYLIC ACID
Label structure11 sections
Dosage and administration
cleanse the skin thoroughly before applying medication. cover the entire affected area with a thin layer one to three times daily. because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. if bothersome dryness or peeling occurs, reduce application to once a day or every other day.
Storage and handling
store away from heat and direct sunlight. store at controlled room temperature: 15°-25°C (59°-77°F).
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
DRUG FACTS
Active Ingredient
Salicylic Acid 2%
Purpose
Acne treatment
Uses
- for the treatment of acne
- dries up acne pimples
- helps prevent new acne pimples
Warnings
For external use only
When using this product
- Using other topical acne medications at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor
Stop use and ask a doctor if
- irritation becomes severe.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- cleanse the skin thoroughly before applying medication.
- cover the entire affected area with a thin layer one to three times daily.
- because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.
- if bothersome dryness or peeling occurs, reduce application to once a day or every other day.
Other Information
- store away from heat and direct sunlight.
- store at controlled room temperature: 15°-25°C (59°-77°F).
Inactive Ingredients
Benzalkonium Chloride, Benzyl Alcohol, Ethoxydiglycol, Fragrance, Glycerin, Menthol, Menthoxypropanediol, Menthyl Lactate, SD Alcohol 40-B (Alcohol Denat.), Ext. Violet 2 (CI 60730), Water.
Questions?
(800) 636-7546 Mon-Fri 9:00 am – 4:00 p.m. Pacific Time
SPL UNCLASSIFIED SECTION
Dist. by OMP, Inc., Long Beach, CA 90806
PRINCIPAL DISPLAY PANEL - 118 mL Bottle Label
OBAGI®
CLENZIderm M.D.™
Pore Therapy
SALICYLIC ACID 2%
ACNE TREATMENT
2
Unclogs pores
and helps
clear skin of
acne-causing
bacteria.
4 FL. OZ. (118 mL)
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1235208 | CLENZIderm M.D. 2 % Pore Therapy Topical Solution | PSN | 1 |
| 251577 | salicylic acid 2 % Topical Solution | PSN | 1 |
| 1235208 | salicylic acid 20 MG/ML Topical Solution [Clenziderm] | SBD | 1 |
| 251577 | salicylic acid 20 MG/ML Topical Solution | SCD | 1 |
| 1235208 | Clenziderm 20 MG/ML Topical Solution | SY | 1 |
| 1235208 | Clenziderm M.D. 2 % Pore Therapy | SY | 1 |
| 251577 | salicylic acid 2 % Topical Solution | SY | 1 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62032-110-60 | 2019-11-13 | C162847 | 48780-1 | 97449f38-cf9e-f6ea-e053-dbdaa90aa703 | OBAGI ® CLENZIderm M.D.™ Pore Therapy |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62032-110-60 | CLENZIDERM PORE THERAPY ACNE TREATMENT | 118 mL in 1 BOTTLE, PLASTIC | LIQUID | 118 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| SALICYLIC ACID | ACTIVE INGREDIENT | O414PZ4LPZ | 1 | |
| SALICYLIC ACID | ACTIVE MOIETY | O414PZ4LPZ | 1 |
Products#
Every source-derived product name is available through these pages.
- CLENZIDERM PORE THERAPY ACNE TREATMENT
- SALICYLIC ACID
- ALCOHOL
- DIETHYLENE GLYCOL MONOETHYL ETHER
- BENZYL ALCOHOL
- 3-((L-MENTHYL)OXY)PROPANE-1,2-DIOL
- GLYCERIN
- BENZALKONIUM CHLORIDE
- MENTHOL
- MENTHYL LACTATE
- EXT. D&C VIOLET NO. 2
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62032-110 | 62032-110-60 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SALICYLIC ACID | O414PZ4LPZ | ACTIB |
| ALCOHOL | 3K9958V90M | IACT |
| DIETHYLENE GLYCOL MONOETHYL ETHER | A1A1I8X02B | IACT |
| BENZYL ALCOHOL | LKG8494WBH | IACT |
| 3-((L-MENTHYL)OXY)PROPANE-1,2-DIOL | KD6TZ2QICH | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | IACT |
| MENTHOL | L7T10EIP3A | IACT |
| MENTHYL LACTATE | 2BF9E65L7I | IACT |
| EXT. D&C VIOLET NO. 2 | G5UX3K0728 | IACT |
| WATER | 059QF0KO0R | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 1d93c707-3b66-4904-bc9c-deda90d26ab8 | 852f01d0-5859-4482-a1fa-91827c964001 | 2011-12-15 | Warnings | 1d93c707-3b66-4904-bc9c-deda90d26ab8 852f01d0-5859-4482-a1fa-91827c964001 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.